Brief: Immunicum Gets Regenerative Medicine Advanced Therapy Designation From FDA

Mendus AB (publ)

06/05/2020 07:56

May 6 (Reuters) - Immunicum AB  IMMUN.ST :
    * REG-IMMUNICUM AB (PUBL) RECEIVES REGENERATIVE MEDICINE
ADVANCED
THERAPY DESIGNATION FROM FDA  FOR ILIXADENCEL IN KIDNEY CANCER

Source text for Eikon:  ID:nGNE6fVlt9 
Further company coverage:  IMMUN.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))